{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T21:30:08Z","timestamp":1772314208142,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Purpose<\/jats:title>\n<jats:p>Modern liver surgery has improved the percentage of potentially resectable malignant tumors. However, if the future liver remnant is small, patients remain at risk of developing postoperative liver failure. Thus, the future liver remnant must be increased, while at the same time, the primary tumor may have to be controlled by chemotherapy. To address this conflict, we retrospectively analyzed the changes in hypertrophy before and after Associating Liver Partition with Portal vein ligation for Staged hepatectomy (ALPPS) or Portal Vein Embolization (PVE), with or without parallel systemic chemotherapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Materials and Methods<\/jats:title>\n<jats:p>We retrospectively analysed 172 patients (54 female and 118 male), treated with ALPPS in 90 patients (median age 61 years [Q1, Q3: 52,71]) and with PVE in 82 patients (median age 66 years [Q1, Q3: 56,73]). The median control interval was 4.9 [Q1, Q3: 4.0, 6.0] weeks after the PVE, and 2.6 [Q1, Q3: 1.6, 5.8] weeks after ALPPS step 1.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The overall kinetic growth rate (median) for the entire group was 0.02 (2%) per week. When systemic chemotherapy was administered prior to intervention, the kinetic growth rate of these treated patients (vs. untreated) exhibited a median of 0.020 [Q1, Q3: 0.011, 0.067] compared to 0.024 [Q1, Q3: 0.013, 0.041] (p\u2009= 0.949). When chemotherapy was administered after the PVE\/ ALPPS treatment, the kinetic growth rate declined from a median of 0.025 [Q1, Q3: 0.013, 0.053] to 0.011 [Q1, Q3: 0.007, 0.021] (p\u2009= 0.005). Subgroup analysis showed statistically significant effects only in the PVE group (median ALPPS -45% (p\u2009= 0.157), PVE -47% (p\u2009= 0.005)).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This retrospective analysis indicated that systemic chemotherapy given after PVE\/ the first step of the ALPPS procedure, i.e., the growth phase, has a negative effect on the kinetic growth rate.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0307937","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T18:22:30Z","timestamp":1741371750000},"page":"e0307937","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-1378","authenticated-orcid":true,"given":"Klara","family":"Welcker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Reese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ehrenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hauke","family":"Weilert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8715-3349","authenticated-orcid":true,"given":"Axel","family":"Stang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1636-7865","authenticated-orcid":true,"given":"Peter","family":"Wohlmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia-Maria","family":"Warnke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8321-7449","authenticated-orcid":true,"given":"Carolin","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"von Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl J.","family":"Oldhafer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas H.","family":"Mahnken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"1","key":"pone.0307937.ref001","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","article-title":"Preoperative portal vein embolization for major liver resection: a meta-analysis","volume":"247","author":"A Abulkhir","year":"2008","journal-title":"Ann Surg"},{"issue":"6","key":"pone.0307937.ref002","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archsurg.137.6.675","article-title":"Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization","volume":"137","author":"EK Abdalla","year":"2002","journal-title":"Arch Surg"},{"issue":"5","key":"pone.0307937.ref003","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000658-200011000-00008","article-title":"Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver","volume":"232","author":"D Azoulay","year":"2000","journal-title":"Ann Surg"},{"issue":"3","key":"pone.0307937.ref004","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1091-255X(02)00370-0","article-title":"Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection","volume":"7","author":"M Shoup","year":"2003","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"pone.0307937.ref005","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/bjs.5836","article-title":"Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome","volume":"94","author":"D Ribero","year":"2007","journal-title":"Br J Surg"},{"issue":"3","key":"pone.0307937.ref006","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"255","author":"AA Schnitzbauer","year":"2012","journal-title":"Ann Surg"},{"key":"pone.0307937.ref007","first-page":"273641","article-title":"Intraoperative conversion to ALPPS in a case of intrahepatic cholangiocarcinoma","author":"F Oldhafer","year":"2015","journal-title":"Case Rep Surg"},{"issue":"1","key":"pone.0307937.ref008","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiology.188.1.8511321","article-title":"Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery","volume":"188","author":"T de Baere","year":"1993","journal-title":"Radiology"},{"issue":"2","key":"pone.0307937.ref009","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiol.2015141858","article-title":"Portal Venous Interventions: State of the Art","volume":"278","author":"DC Madoff","year":"2016","journal-title":"Radiology"},{"issue":"5","key":"pone.0307937.ref010","first-page":"1176","article-title":"Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors","volume":"26","author":"K Kubota","year":"1997","journal-title":"Hepatology"},{"issue":"9","key":"pone.0307937.ref011","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/bjs.7194","article-title":"Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection","volume":"97","author":"VE de Meijer","year":"2010","journal-title":"Br J Surg"},{"issue":"1","key":"pone.0307937.ref012","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s42155-021-00227-5","article-title":"Ipsilateral access portal venous embolization (PVE) for preoperative hypertrophy exhibits low complication rates in Clavien-Dindo and CIRSE scales","volume":"4","author":"R Br\u00fcning","year":"2021","journal-title":"CVIR Endovasc"},{"issue":"4","key":"pone.0307937.ref013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21614\/chirurgia.116.4.409","article-title":"ALPPS Procedure. The New Frontier in Advanced Liver Surgery. Single Centre Experience and Literature Review","volume":"116","author":"A Hotineanu","year":"2021","journal-title":"Chirurgia (Bucur)"},{"key":"pone.0307937.ref014","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13037-016-0104-y","article-title":"Monitoring of liver function in a 73-year old patient undergoing \u201cAssociating Liver Partition and Portal vein ligation for Staged hepatectomy\u201d: case report applying the novel liver maximum function capacity test","volume":"10","author":"F Oldhafer","year":"2016","journal-title":"Patient Saf Surg"},{"issue":"5","key":"pone.0307937.ref015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/msy.2000.105294","article-title":"Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations","volume":"127","author":"JN Vauthey","year":"2000","journal-title":"Surgery"},{"issue":"17","key":"pone.0307937.ref016","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"RD Mosteller","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0307937.ref017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jamcollsurg.2012.10.018","article-title":"Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant","volume":"216","author":"J Shindoh","year":"2013","journal-title":"J Am Coll Surg"},{"key":"pone.0307937.ref018","article-title":"A language and environment for statistical computing","author":"R Core Team.","year":"2021","journal-title":"R Project for Statistical Computing"},{"issue":"2","key":"pone.0307937.ref019","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/2515245919847202","article-title":"Evaluating effect size in psychological research: sense and nonsense","volume":"2","author":"DC Funder","year":"2019","journal-title":"Adv. Methods Pract. Psychol. Sci"},{"issue":"3","key":"pone.0307937.ref020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3350\/cmh.2014.20.3.317","article-title":"Chemotherapy induced liver abnormalities: an imaging perspective","volume":"20","author":"A Sharma","year":"2014","journal-title":"Clin Mol Hepatol"},{"issue":"46","key":"pone.0307937.ref021","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.3748\/wjg.v27.i46.7866","article-title":"Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis","volume":"27","author":"L Calistri","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"942","key":"pone.0307937.ref022","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1259\/bjr\/29855825","article-title":"Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy","volume":"79","author":"IK Beal","year":"2006","journal-title":"Br J Radiol"},{"issue":"3-4","key":"pone.0307937.ref023","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000356297","article-title":"Prediction of the remnant liver hypertrophy ratio after preoperative portal vein embolization","volume":"51","author":"Y Kasai","year":"2013","journal-title":"Eur Surg Res"},{"key":"pone.0307937.ref024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5114\/aoms.2013.33348","article-title":"Prognostic importance of some clinical and therapeutic factors for the effect of portal vein embolization in patients with primarily inoperable colorectal liver metastases","volume":"1","author":"V Treska","year":"2011","journal-title":"Archives of Medical Science"},{"issue":"8","key":"pone.0307937.ref025","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1245\/s10434-010-0979-2","article-title":"Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization","volume":"17","author":"T de Baere","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"pone.0307937.ref026","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2214\/AJR.04.1593","article-title":"Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases","volume":"185","author":"AM Covey","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"pone.0307937.ref027","doi-asserted-by":"crossref","first-page":"114760","DOI":"10.1016\/j.taap.2019.114760","article-title":"Chemotherapeutic doses of arsenic trioxide delays hepatic regeneration by oxidative stress and hepatocyte apoptosis in partial hepatectomy rat","volume":"382","author":"S Nithyananthan","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"pone.0307937.ref028","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.ejso.2015.08.152","article-title":"Hepatic regeneration in a rat model is impaired by chemotherapy agents used in metastatic colorectal cancer","volume":"41","author":"C Hubert","year":"2015","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"key":"pone.0307937.ref029","doi-asserted-by":"crossref","first-page":"1756284820924194","DOI":"10.1177\/1756284820924194","article-title":"Chemotherapy-associated liver injury in colorectal cancer","volume":"13","author":"A Gangi","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"issue":"3","key":"pone.0307937.ref030","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6030026","article-title":"Portal vein embolization: impact of chemotherapy and genetic mutations","volume":"6","author":"AR Deipolyi","year":"2017","journal-title":"J Clin Med"},{"issue":"33","key":"pone.0307937.ref031","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"3rd Blazer DG","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"pone.0307937.ref032","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1872-034X.2009.00599.x","article-title":"Serum HGF and TGF-\u03b21 levels after right portal vein embolization","volume":"40","author":"H Hayashi","year":"2010","journal-title":"Hepatology Research"},{"issue":"7","key":"pone.0307937.ref033","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/02841850701424514","article-title":"Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization","volume":"48","author":"S Hayashi","year":"2007","journal-title":"Acta Radiol"},{"issue":"7","key":"pone.0307937.ref034","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1477-2574.2012.00476.x","article-title":"Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases","volume":"14","author":"E Simoneau","year":"2012","journal-title":"HPB (Oxford)"},{"issue":"6","key":"pone.0307937.ref035","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s00268-013-2401-2","article-title":"ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence","volume":"38","author":"KJ Oldhafer","year":"2014","journal-title":"World J Surg"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T18:22:45Z","timestamp":1741371765000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307937"}},"subtitle":[],"editor":[{"given":"Gregory","family":"Tiao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0307937","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}